These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16964598)

  • 1. Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy.
    Köstler H; Landschütz W; Koeppe S; Seyfarth T; Lipke C; Sandstede J; Spindler M; von Kienlin M; Hahn D; Beer M
    Magn Reson Med; 2006 Oct; 56(4):907-11. PubMed ID: 16964598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
    Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
    Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
    Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
    J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].
    Beer M; Landschütz W; Meininger M; Seyfarth T; Viehrig M; Sandstede J; Pabst T; Kenn W; Horn M; Harre K; von Kienlin M; Neubauer S; Hahn D
    Rofo; 1999 Jul; 171(1):65-8. PubMed ID: 10464508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
    Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
    J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.
    Meininger M; Landschütz W; Beer M; Seyfarth T; Horn M; Pabst T; Haase A; Hahn D; Neubauer S; von Kienlin M
    Magn Reson Med; 1999 Apr; 41(4):657-63. PubMed ID: 10332840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition-weighted chemical shift imaging improves SLOOP quantification of human cardiac phosphorus metabolites.
    Geier O; Weng AM; Toepell A; Hahn D; Spindler M; Beer M; Köstler H
    Z Med Phys; 2014 Mar; 24(1):49-54. PubMed ID: 23375741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
    Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
    Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS.
    Okada M; Mitsunami K; Inubushi T; Kinoshita M
    Magn Reson Med; 1998 May; 39(5):772-82. PubMed ID: 9581609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [31P Magnetic Resonance Spectroscopy in Patients With Various Genesis of Left Ventricular Hypertrophy].
    Ternovoy SK; Mazaev VV; Stukalova OV; Serova NS
    Kardiologiia; 2015; 55(9):5-9. PubMed ID: 26898088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy.
    Beer M; Schneider C; Köstler H; Buchner S; Sandstede J; Toyka KV; Hahn D
    Rofo; 2002 May; 174(5):573-8. PubMed ID: 11997856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging.
    Caus T; Kober F; Marin P; Mouly-Bandini A; Quilici J; Métras D; Cozzone PJ; Bernard M
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):45-9. PubMed ID: 16343922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
    Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
    Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of human cardiac 31P-NMR spectroscopy.
    Lamb HJ; Doornbos J; den Hollander JA; Luyten PR; Beyerbacht HP; van der Wall EE; de Roos A
    NMR Biomed; 1996 Aug; 9(5):217-27. PubMed ID: 9068003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of myocardial infarctions by acquisition-weighted 31P-MR spectroscopy in humans.
    Beer M; Spindler M; Sandstede JJ; Remmert H; Beer S; Köstler H; Hahn D
    J Magn Reson Imaging; 2004 Nov; 20(5):798-802. PubMed ID: 15503333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of myocardial energy metabolism by 31 P-magnetic resonance spectroscopy in patients with hypertrophic cardiomyopathy versus healthy individuals].
    Mazaev VV; Stukalova OV; Ternovoĭ SK; Chazova IE
    Vestn Rentgenol Radiol; 2012; (6):8-12. PubMed ID: 23520935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical cardiac magnetic resonance spectroscopy--present state and future directions.
    Neubauer S; Horn M; Hahn D; Kochsiek K
    Mol Cell Biochem; 1998 Jul; 184(1-2):439-43. PubMed ID: 9746338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise-induced decrease in myocardial high-energy phosphate metabolites in patients with Chagas heart disease.
    Betim Paes Leme AM; Salemi VM; Weiss RG; Parga JR; Ianni BM; Mady C; Kalil-Filho R
    J Card Fail; 2013 Jul; 19(7):454-60. PubMed ID: 23834921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.